Israel Active

Personally tailored treatments for cancer patients are well known. Now Tel Aviv University researchers propose a similar approach to fighting infections. Two immune markers in the blood indicate which medication and dosage can best fight the pathogen and repair the damage.

Israel’s Avertto won the 2023 Hebrew University Asper Prize. Most stroke patients do not reach the emergency room on time. Avertto’s system monitors blood flow to the brain, detects any changes and provides real-time alerts to enable timely treatment, thereby preventing strokes.

The Israeli nonprofit Start-Up Nation Central has announced a new initiative, Hospital2Hospital, to partner South Florida’s Baptist Health Innovations and Israel’s Sheba Medical Center’s ARC Innovation. Israeli startups will compete for a $75,000 grant to help launch in the US.

This brief video summarizes the successes of Israel’s leading hospital – Sheba Medical Center. It emphasizes Sheba’s ethos of innovation, compassion, and a commitment to a global well-being.  Advancing healthcare not only to Israelis, but to the citizens of the world.

Healthcare organization Ballad Health, serving around a million people in 29 US counties, is adopting the AI-powered drug safety platform from Israel’s MedAware (see previously). The system identifies potential medication-related errors.

Bar-Ilan University graduate Aviv Mesika has developed the LacriScan diagnosis test which uses a patient’s tears to diagnose Alzheimer’s and Parkinson’s in their pre-symptom stages. The new test is more sensitive than previous ones and checks for multiple brain chemical markers of the two diseases.

Israel’s Actic Medical has developed the Hybrid+ insole. It has sensors that can measure the pressure, temperature, and motion of the foot to inform the wearer of impending foot ulcers. The patient then uses a special screwdriver to change the insole’s shape to redistribute the pressure.

The Sheba Pandemic Research Institute (SPRI) is partnering with the US National Institutes of Health (NIH) and others to develop a pan-coronavirus booster vaccine. The vaccine will also be applied to other viruses, including influenza, with the goal of preventing future pandemics.

Israel’s FertiliFit is developing a solution that uses AI-based technology to personalize IVF (and IUI) treatment to the specific patient.  Its deep learning model inputs the patient’s medical history, physiology, hormone levels etc., to identify the best treatment and the probability of success.

Researchers at Tel Aviv University encoded a toxin into mRNA (messenger RNA) molecules and delivered them directly to cancer cells. The cells were instructed to produce the toxin that eventually killed them. Another breakthrough from the lab of Professor Dan Peer.